News: Basilea

News

News Subscription

Feb 20. 2017

Basilea reports solid 2016 results and expects to double product sales in 2017

Read more

Dec 29. 2016

Basilea names new member of its Extended Management Committee

Read more

Dec 02. 2016

Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients

Read more

Nov 15. 2016

Basilea's antifungal Cresemba® (isavuconazole) launched in France

Read more

Sep 20. 2016

Basilea announces distribution agreement with Unimedic for CRESEMBA® (isavuconazole) and Zevtera® (ceftobiprole) in the Nordic countries

Read more

Sep 15. 2016

Basilea announces partnership for antifungal isavuconazole in Japan with Asahi Kasei Pharma

Read more

Sep 13. 2016

Basilea announces supply, distribution and license agreement with Grupo Biotoscana for CRESEMBA® (isavuconazole) and Zevtera® (ceftobiprole) in Latin America

Read more

Sep 06. 2016

Basilea starts continuous infusion phase 1/2a clinical study with oncology drug candidate BAL101553

Read more

Aug 17. 2016

Basilea announces distribution agreement with Hikma for CRESEMBA® (isavuconazole) in the MENA region

Read more

Aug 15. 2016

Basilea reports 2016 half-year results - CRESEMBA® launched in key European markets

Read more

previous
1
…
22
23
24
…
32
next